AC Immune Announces the Selection of Tau Small Molecules for Clinical Development in Alzheimer’s disease
Pharmaceutical Investing Denali Therapeutics Announces Reports Full Year 2017 Financial Results And Business Highlights
Pharmaceutical Investing Novartis and Pear Therapeutics to develop digital therapeutics for patients with schizophrenia and multiple sclerosis
ProMIS Neurosciences Lead Product Candidate for Alzheimer’s Disease Shows Potential for Improved Therapeutic Potency
Noble Mineral highlights Successful Exploration Results announced by Canada Nickel, including Highest Grade to Date at Mann West
CHARBONE Hydrogen and ABB Sign Agreement to Advance North American Green Hydrogen Production Facilities